E-LIB Suche - Ergebnisse für: Austin, R. Marshall

1

The Clinical Utility of Extended High-Risk HPV Genotyping i..:

Jiang, Wei ; Austin, R Marshall ; Zhang, Huina...
American Journal of Clinical Pathology. 158 (2022) 4 - p. 472-479 , 2022

Link: https://doi.org/10.1093/..

2

The significant remaining challenge of screening for cervic..:

Jones, Terri E. ; Austin, R. Marshall
Journal of the American Society of Cytopathology. 11 (2022) 1 - p. 1-2 , 2022

Link: https://doi.org/10.1016/..

3

Trends in Papanicolaou Test Cytology and HPV Testing in a L..:

Jones, Terri ; Matsko, Jonee ; Austin, R. Marshall.
Journal of the American Society of Cytopathology. 11 (2022) 6 - p. S11-S12 , 2022

Link: https://doi.org/10.1016/..

4

Change of Practice Patterns Following an Educational Commen..:

Jones, Terri E ; Onisko, Agnieszka ; Austin, R Marshall.
American Journal of Clinical Pathology. 157 (2021) 3 - p. 413-416 , 2021

Link: https://doi.org/10.1093/..

5

Risk-based cervical screening guidelines should utilize lar..:

Austin, R. Marshall ; Zhao, Chengquan
Gynecology and Obstetrics Clinical Medicine. 1 (2021) 1 - p. 2-4 , 2021

Link: https://doi.org/10.1016/..

6

Aptima HPV messenger RNA testing and histopathologic follow..:

Li, Aofei ; Li, Juan ; Austin, R. Marshall...
Cancer Cytopathology. 129 (2021) 8 - p. 622-631 , 2021

Link: https://doi.org/10.1002/..

7

Nationwide Prevalence and Genotype Distribution of High-Ris..:

Zeng, Zhengyu ; Austin, R Marshall ; Wang, Lin...
American Journal of Clinical Pathology. 157 (2021) 5 - p. 718-723 , 2021

Link: https://doi.org/10.1093/..

8

Risk stratification for cervical neoplasia using extended h..:

Tao, Xiang ; Austin, R. Marshall ; Yu, Ting...
Cancer Cytopathology. 130 (2021) 4 - p. 248-258 , 2021

Link: https://doi.org/10.1002/..

9

Are CIN3 risk or CIN3+ risk measures reliable surrogates fo..:

Austin, R. Marshall ; Onisko, Agnieszka ; Zhao, Chengquan
Journal of the American Society of Cytopathology. 9 (2020) 6 - p. 602-606 , 2020

Link: https://doi.org/10.1016/..

10

Contributions of Liquid-Based (Papanicolaou) Cytology and H..:

Kaufman, Harvey W ; Alagia, Damian P ; Chen, Zhen..
American Journal of Clinical Pathology. 154 (2020) 4 - p. 510-516 , 2020

Link: https://doi.org/10.1093/..

11

Individualized Bayesian Risk Assessment for Cervical Squamo..:

Farchoukh, Lama F. ; Onisko, Agnieszka ; Austin, R. Marshall
Journal of Pathology Informatics. 11 (2020) 1 - p. 9 , 2020

Link: https://doi.org/10.4103/..

12

Cotesting in Cervical Cancer Screening:

Malinowski, Douglas P ; Broache, Molly ; Vaughan, Laurence...
American Journal of Clinical Pathology. 155 (2020) 1 - p. 150-154 , 2020

Link: https://doi.org/10.1093/..

13

What Constitutes Optimal Cervical Screening for Young Women..:

Zhao, Chenquan ; Austin, R Marshall
American Journal of Clinical Pathology. 153 (2020) 6 - p. 712-714 , 2020

Link: https://doi.org/10.1093/..

14

Nationwide survey of cervical cytology laboratory practices..:

Tao, Xiang ; Austin, R. Marshall ; Kong, Lingfei...
Journal of the American Society of Cytopathology. 8 (2019) 5 - p. 250-257 , 2019

Link: https://doi.org/10.1016/..

15

The impact of primary HPV screening on the incidence of cer..:

Cox, Brian ; Fitzgerald, Peter ; Austin, R. Marshall.
Journal of the American Society of Cytopathology. 8 (2019) 5 - p. 258-264 , 2019

Link: https://doi.org/10.1016/..